Iron chelation with oral deferiprone in patients with thalassemia

N Engl J Med. 1998 Dec 3;339(23):1710; author reply 1713-4. doi: 10.1056/NEJM199812033392313.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biopsy
  • Deferiprone
  • Humans
  • Iron Chelating Agents / adverse effects*
  • Iron Chelating Agents / therapeutic use
  • Iron Overload / drug therapy*
  • Iron Overload / pathology
  • Liver Cirrhosis / etiology*
  • Liver Cirrhosis / pathology
  • Pyridones / adverse effects*
  • Pyridones / therapeutic use
  • beta-Thalassemia / pathology*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone